Arcutis Biotherapeutics (ARQT)
(Real Time Quote from BATS)
$9.60 USD
-0.12 (-1.24%)
Updated Oct 17, 2024 11:42 AM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 37% (93 out of 250)Zacks Sector Rank
Top 6% (1 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.43 | 1.37 | 9.99 |
Current Quarter Estimate | -0.40 | 2.59 | 63.00 |
Year Ago Quarter Estimate | -0.73 | -4.98 | 52.25 |
Next Quarter Estimate | -0.36 | 3.37 | 66.00 |
Next Year Estimate | -1.18 | 23.17 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 58.73 | 17.50 | 15.67 |
Next Year | 24.36 | 10.10 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.28 |
Price/Book (MRQ) | 6.04 | 1.95 |
Price/Cash Flow (MRFY) | NA | 14.78 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -150.51% | -101.26% |
Return on Equity (TTM) | -145.41% | -66.38% |
Debt to Equity (MRQ) | NA | 40.92 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.